Image 2_EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer.jpg

Background<p>Epidermal growth factor receptor (EGFR) is a key protein in cellular signaling that is overexpressed in many human cancers, making it a compelling therapeutic target. On-target severe skin toxicity has limited its clinical application. Dual-targeting therapy represents a novel app...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Huilin Cui (6505856) (author)
مؤلفون آخرون:	Qianqian Yu (114057) (author), Qumiao Xu (12601776) (author), Chen Lin (95910) (author), Long Zhang (315279) (author), Wei Ye (105005) (author), Yifei Yang (585215) (author), Sijia Tian (12079175) (author), Yilu Zhou (8281596) (author), Runzhe Sun (20344488) (author), Yongsheng Meng (9959977) (author), Ningning Yao (8995259) (author), Haizhen Wang (346885) (author), Feilin Cao (194046) (author), Meilin Liu (490419) (author), Jinfeng Ma (514021) (author), Cheng Liao (1492417) (author), Ruifang Sun (7623572) (author)
منشور في:	2024
الموضوعات:	Oncology and Carcinogenesis not elsewhere classified EGFR MUC1 TAA LUAD CRC
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Image 2_EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer.jpg

مواد مشابهة